CNBX Pharmaceuticals Inc.
CNBX
$0.0023
$0.000315.00%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -102.91% | 43.23% | 53.60% | 59.88% | -82.35% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -16.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.48% | -91.14% | -- | -100.00% | 253.45% |
| Change in Net Operating Assets | 278.21% | 65.49% | -117.28% | 3,014.29% | -79.81% |
| Cash from Operations | -32.23% | 19.05% | -24,250.00% | 100.16% | -73.26% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 373.50% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00% | 373.50% | 1,766.67% |
| Total Debt Issued | 166.67% | 2,207.69% | 0.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 166.67% | 2,207.69% | 0.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -200.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 410.99% | 80.64% | -229.48% | 181.57% | 7.29% |